Armed with confidential information about how the Food and Drug Administration was going to rule on experimental drugs, an agency chemist and his son allegedly made more than $2.27 million by trading in shares of five companies.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/03/29/134960063/fda-chemist-and-son-charged-with-insider-trading?ft=1&f=103537970
Posted
Mar 29 2011, 01:57 PM
by
NPR Blogs: Shots - Health Blog